Aehr Test Systems (AEHR) - Stock Analysis
Last updated: Apr 4, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25â30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong liquidity ⢠Compressed margins ⢠High workingâcapital Aehr shows strong liquidity and low leverage but deteriorating margins, rising operating losses, and heavy working-capital drag that challenge profitability and valuation.
Price Behavior
Key Price Behavior Insights: ⢠Clear breakout ⢠Rapid rally ⢠Pullback risk Support Level: $37.0â$38.5; stronger support $30.12 Resistance Level: $44.3 AEHR has broken out last month into a clear short-term uptrend (closing $44.32) well above the ~$37.7 average, showing strong momentum but a rapid ~47% rise from $30.12 that raises near-term pullback risk.
Sentiment & News
Key News Insights: ⢠AI/data-center wins ⢠Sharp share rally ⢠Weak fundamentals Aehr Test Systems is seeing investor-driven rallies on AI/data-center silicon-photonics wins and a major customer order despite weak recent revenue and profitability, mixed analyst views, and stretched valuation ahead of fiscal Q3 results.
AI Summary
Aehr's transition from an R&D vendor to an early commercial supplier with productionâlevel AI and siliconâphotonics wins meaningfully raises upside if a few large programs scale into repeatable, higherâmargin production â but the investment now hinges on execution timing and customer concentration. Investors should make exposure conditional: validate by Q3 revenue/margin delivery, multiâquarter repeat bookings beyond single orders, and rapid inventory conversion before increasing positions; a miss likely triggers sharp downside given the current valuation and momentum.
Description
Aehr Test Systems designs and supplies test and burn-in equipment for logic, memory and optical integrated circuits, supporting both wafer-level and packaged-device verification. Its product set includes systems and handling solutions that enable full-wafer contact testing, singulated die and module burn-in, and compact single-wafer reliability checks across a range of device types and power levels. The company was incorporated in 1977 and is based in Fremont, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 2 | Apr 9 | AEHR | Aehr Test Systems | High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25â30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup. | Closed | +55.4% |
| Mar 9 | Mar 16 | AEHR | Aehr Test Systems | Semicap name with stacked recent orders: in Febâearly Mar 2026 announced multiple production-stage and wafer-level burn-in orders (including a $14M FOX + WaferPak order on 2026-02-26 and a follow-on silicon-photonics order on 2026-03-03). Stock ran ~55% into a 44.03 high then pulled back ~19% to 35.61 by 2026-03-06, leaving a high-volatility setup where confirmation of order-to-revenue conversion could trigger another sharp upside leg. | Closed | -8.3% |
| Feb 23 | Mar 2 | AEHR | Aehr Test Systems | An initial production purchase order from a leading hyperscaler for multiple Sonoma systems and more than $5.5m in recent Q3 orders, tied to nextâgen AI processors, is catalyzing strong technical momentum (break around $34) and elevated investor interest, positioning AEHR for nearâterm upside as those orders convert to reported revenue despite weak recent cash flow and margins. | Closed | +28.3% |
| Dec 17 | Dec 24 | AEHR | Aehr Test Systems | Record Q3 revenues with strong AI/data center product demand, production capacity expansion, institutional buying, and improving gross margins underpin short-term growth, although unprofitability and technical price volatility suggest cautious optimism. | Closed | +2.7% |